SynthesisDiabetes/metabolism research and reviews2025

Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Other Glucose-Lowering Agents in People With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Data.

Alisa Fishkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.